{"transactions":[{"id":689315,"issuer":{"id":3796,"kind":"organization","name":"Erasca, Inc."},"owners":[{"id":24149,"kind":"person","name":"Fuchs Charles S.","position":1,"cik":"0001719576","reported_name":"Fuchs Charles S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Stock option (right to buy)","published_at":"2026-08-12T20:22:08.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":1300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported option award was granted in connection with the Reporting Person's commencement of employment. Of the total option award, 21,480 shares were granted under the Issuer's 2021 Incentive Award Plan, with a portion intended to qualify as an incentive stock option under Section 422 of the Internal Revenue Code to the extent permitted by law. The remaining 1,278,520 shares were granted as a nonqualified stock option under the Issuer's 2026 Employment Inducement Incentive Award Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported option award vests as follows: 25% of the shares subject to the option will vest on the first anniversary of the date of grant, and the remaining 75% of the shares will vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date."}],"balance_after":1300000,"derivative":{"exercise_price":18.12,"exercise_date":"2027-08-10","expiration_date":"2036-08-09","underlying":"Common Stock","underlying_shares":1300000},"source":{"system":"sec-edgar","filing":"0001193125-26-346924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761918/000119312526346924/ownership.xml","form_type":"4"}},{"id":700521,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":24149,"kind":"person","name":"Fuchs Charles S.","position":1,"cik":"0001719576","reported_name":"Fuchs Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-30T21:07:20.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from July 24, 2026 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":118000,"derivative":{"exercise_price":3.24,"expiration_date":"2036-07-23","underlying":"Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001610717-26-000345","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071726000345/form4.xml","form_type":"4"}},{"id":3106474,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":24149,"kind":"person","name":"Fuchs Charles S.","position":1,"cik":"0001719576","reported_name":"Fuchs Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-17T21:06:48.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":8.35,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-20-012298","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920012298/doc1.xml","form_type":"4"}},{"id":3480989,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":24149,"kind":"person","name":"Fuchs Charles S.","position":1,"cik":"0001719576","reported_name":"Fuchs Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T18:03:39.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":11.31,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001567619-19-013824","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761919013824/doc1.xml","form_type":"4"}},{"id":3892138,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":24149,"kind":"person","name":"Fuchs Charles S.","position":1,"cik":"0001719576","reported_name":"Fuchs Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T21:52:39.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":25.25,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0000899243-18-016824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000089924318016824/doc4.xml","form_type":"4"}},{"id":4181088,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":24149,"kind":"person","name":"Fuchs Charles S.","position":1,"cik":"0001719576","reported_name":"Fuchs Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-10-24T19:26:01.000Z","date":"2017-10-23","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from October 23, 2017 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":28000,"derivative":{"exercise_price":20.04,"expiration_date":"2027-10-22","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001140361-17-039390","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117039390/doc1.xml","form_type":"4"}}]}